Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$397.48 USD
-0.22 (-0.06%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $397.50 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Earnings News For VRTX
-
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
-
Vertex (VRTX) Down 0.2% Since Last Earnings Report: Can It Rebound?
-
Vertex's (VRTX) Q4 Earnings and Sales Surpass Estimates
-
Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates
-
Vertex: Q4 Earnings Snapshot
-
Vertex: Q4 Earnings Snapshot
-
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
-
Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?
-
Why Is Vertex (VRTX) Down 6.4% Since Last Earnings Report?
-
Vertex (VRTX) Q3 Earnings Beat, Sales Miss, Raises '23 View
-
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings Estimates
-
Vertex: Q3 Earnings Snapshot
-
Vertex Reports Third Quarter 2023 Financial Results
-
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy?
-
Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?
-
Vertex (VRTX) Down 2.1% Since Last Earnings Report: Can It Rebound?
-
Vertex (VRTX) Beats on Q2 Earnings & Sales, Raises '23 View
-
Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Top Estimates
-
Vertex: Q2 Earnings Snapshot
-
Vertex Reports Second Quarter 2023 Financial Results
-
Vertex (VRTX) to Report Q2 Earnings: What's in the Cards?
-
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
-
Why Is Vertex (VRTX) Down 6% Since Last Earnings Report?
-
Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/Y
-
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Surpass Estimates